PARIS (Reuters) – Healthcare and clinical diagnostics company Novacyt announced more contract wins for its ‘Primerdesign’ product aimed at testing for the presence of the coronavirus, although the company suffered a minor setback in France.
Novacyt said it had total sales and confirmed orders worth 135 million euros ($150.3 million) for the product, with new wins in Zimbabwe and across Latin America.
Novacyt added that France’s ‘Haute Autorite de Sante’ regulatory body had not approved Primerdesign’s test for reimbursement in France, although Novacyt said it could still sell the test in France for private patient testing.
Reporting by Sudip Kar-Gupta, editing by Louise Heavens
vCard.red is a free platform for creating a mobile-friendly digital business cards. You can easily create a vCard and generate a QR code for it, allowing others to scan and save your contact details instantly.
The platform allows you to display contact information, social media links, services, and products all in one shareable link. Optional features include appointment scheduling, WhatsApp-based storefronts, media galleries, and custom design options.